NICE approves monoclonal antibody dupilumab for severe asthma Post date 18 October 2021 ← Covid-19: Valneva’s vaccine produces stronger immune response than AstraZeneca’s, company reports → LGBT+: Indian medical institutions are asked to amend textbooks with unscientific content